Innoviva
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.About INVA
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.
CEOPavel Raifeld
CEOPavel Raifeld
Employees127
Employees127
HeadquartersBurlingame, California
HeadquartersBurlingame, California
Founded1996
Founded1996
Employees127
Employees127
INVA Key Statistics
Market cap1.18B
Market cap1.18B
Price-Earnings ratio-18.85
Price-Earnings ratio-18.85
Dividend yield—
Dividend yield—
Average volume1.01M
Average volume1.01M
High today$19.40
High today$19.40
Low today$18.75
Low today$18.75
Open price$19.40
Open price$19.40
Volume750.57K
Volume750.57K
52 Week high$22.00
52 Week high$22.00
52 Week low$16.67
52 Week low$16.67
People also own
Based on the portfolios of people who own INVA. This list is generated using Robinhood data, and it’s not a recommendation.